229 related articles for article (PubMed ID: 6298791)
1. Identification of adenylate cyclase-stimulating activity and cytochemical glucose-6-phosphate dehydrogenase-stimulating activity in extracts of tumors from patients with humoral hypercalcemia of malignancy.
Stewart AF; Insogna KL; Goltzman D; Broadus AE
Proc Natl Acad Sci U S A; 1983 Mar; 80(5):1454-8. PubMed ID: 6298791
[TBL] [Abstract][Full Text] [Related]
2. Two species of adenylate cyclase-stimulating activity in a murine squamous carcinoma model of humoral hypercalcemia of malignancy.
Burtis WJ; Broadus AE; Insogna KL; Weir EC; Stewart AF
Endocrinology; 1986 May; 118(5):1982-8. PubMed ID: 3009144
[TBL] [Abstract][Full Text] [Related]
3. Synthetic peptides comprising the amino-terminal sequence of a parathyroid hormone-like protein from human malignancies. Binding to parathyroid hormone receptors and activation of adenylate cyclase in bone cells and kidney.
Nissenson RA; Diep D; Strewler GJ
J Biol Chem; 1988 Sep; 263(26):12866-71. PubMed ID: 2843501
[TBL] [Abstract][Full Text] [Related]
4. Cerebral vascular adenylate cyclase: evidence for coupling to receptors for vasoactive intestinal peptide and parathyroid hormone.
Huang M; Rorstad OP
J Neurochem; 1984 Sep; 43(3):849-56. PubMed ID: 6086840
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship of parathyroid hormone: relative sensitivity of rabbit renal microvessel and tubule adenylate cyclases to oxidized PTH and PTH inhibitors.
Helwig JJ; Yang MC; Bollack C; Judes C; Pang PK
Eur J Pharmacol; 1987 Aug; 140(3):247-57. PubMed ID: 2820761
[TBL] [Abstract][Full Text] [Related]
6. Evidence for adenylyl cyclase-dependent receptors for parathyroid hormone (PTH)-related protein in rabbit kidney glomeruli.
Massfelder T; Saussine C; Simeoni U; Enanga B; Judes C; Helwig JJ
Life Sci; 1993; 53(11):875-81. PubMed ID: 8396186
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel 17,000-dalton parathyroid hormone-like adenylate cyclase-stimulating protein from a tumor associated with humoral hypercalcemia of malignancy.
Burtis WJ; Wu T; Bunch C; Wysolmerski JJ; Insogna KL; Weir EC; Broadus AE; Stewart AF
J Biol Chem; 1987 May; 262(15):7151-6. PubMed ID: 3584110
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of in vitro bone resorption by a parathyroid hormone receptor antagonist in the canine adenocarcinoma model of humoral hypercalcemia of malignancy.
Rosol TJ; Capen CC
Endocrinology; 1988 May; 122(5):2098-102. PubMed ID: 2834184
[TBL] [Abstract][Full Text] [Related]
9. Synthetic and partially-purified adenylate cyclase-stimulating proteins from tumors associated with humoral hypercalcemia of malignancy inhibit phosphate transport in a PTH-responsive renal cell line.
Sartori L; Weir EC; Stewart AF; Broadus AE; Mangin M; Barrett PQ; Insogna KL
J Clin Endocrinol Metab; 1988 Feb; 66(2):459-61. PubMed ID: 3339117
[TBL] [Abstract][Full Text] [Related]
10. Bioactivity of parathyroid hormone and parathyroid hormone-like peptide: agonist and antagonist activities of amino-terminal fragments as assessed by the cytochemical bioassay and in situ biochemistry.
Loveridge N; Dean V; Goltzman D; Hendy GN
Endocrinology; 1991 Apr; 128(4):1938-46. PubMed ID: 2004612
[TBL] [Abstract][Full Text] [Related]
11. The 7-34-fragment of human hypercalcemia factor is a partial agonist/antagonist for parathyroid hormone-stimulated cAMP production.
McKee RL; Goldman ME; Caulfield MP; DeHaven PA; Levy JJ; Nutt RF; Rosenblatt M
Endocrinology; 1988 Jun; 122(6):3008-10. PubMed ID: 2836181
[TBL] [Abstract][Full Text] [Related]
12. Sulfur-free parathyroid hormone analogues containing D-amino acids: biological properties in vitro and in vivo.
Rosenblatt M; Coltrera MD; Shepard GL; Gray DA; Parsons JA; Potts JT
Biochemistry; 1981 Dec; 20(25):7246-50. PubMed ID: 6274393
[TBL] [Abstract][Full Text] [Related]
13. Two forms of parathyroid hormone-like adenylate cyclase-stimulating protein derived from tumors associated with humoral hypercalcemia of malignancy.
Stewart AF; Burtis WJ; Wu T; Goumas D; Broadus AE
J Bone Miner Res; 1987 Dec; 2(6):587-93. PubMed ID: 3455636
[TBL] [Abstract][Full Text] [Related]
14. Malignancy-associated hypercalcemia: evaluation with a cytochemical bioassay for parathyroid hormone.
Goltzman D; Stewart AF; Broadus AE
J Clin Endocrinol Metab; 1981 Nov; 53(5):899-904. PubMed ID: 6270184
[TBL] [Abstract][Full Text] [Related]
15. Separation of parathyroid hormone-like activity from transforming growth factor-alpha and -beta in the canine adenocarcinoma (CAC-8) model of humoral hypercalcemia of malignancy.
Merryman JI; Rosol TJ; Brooks CL; Capen CC
Endocrinology; 1989 May; 124(5):2456-63. PubMed ID: 2539981
[TBL] [Abstract][Full Text] [Related]
16. Bone and kidney adenylate cyclase-stimulating activity produced by a hypercalcemic canine adenocarcinoma line (CAC-8) maintained in nude mice.
Rosol TJ; Capen CC; Brooks CL
Cancer Res; 1987 Feb; 47(3):690-5. PubMed ID: 3467838
[TBL] [Abstract][Full Text] [Related]
17. A tumor-secreted protein associated with human hypercalcemia of malignancy. Biology and molecular biology.
Rosenblatt M; Caulfield MP; Fisher JE; Horiuchi N; Mckee RL; Rodan SB; Thiede MA; Thompson DD; Seedor JG; Nutt RE
Ann N Y Acad Sci; 1988; 548():137-45. PubMed ID: 2854715
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor and interleukin 1 inhibit parathyroid hormone-responsive adenylate cyclase in clonal osteoblast-like cells by down-regulating parathyroid hormone receptors.
Katz MS; Gutierrez GE; Mundy GR; Hymer TK; Caulfield MP; McKee RL
J Cell Physiol; 1992 Oct; 153(1):206-13. PubMed ID: 1325978
[TBL] [Abstract][Full Text] [Related]
19. Frequency and partial characterization of adenylate cyclase-stimulating activity in tumors associated with humoral hypercalcemia of malignancy.
Stewart AF; Insogna KL; Burtis WJ; Aminiafshar A; Wu T; Weir EC; Broadus AE
J Bone Miner Res; 1986 Jun; 1(3):267-76. PubMed ID: 2845726
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of parathyroid hormone receptors in renal membranes from aged rats.
Hanai H; Brennan DP; Cheng L; Goldman ME; Chorev M; Levine MA; Sacktor B; Liang CT
Am J Physiol; 1990 Sep; 259(3 Pt 2):F444-50. PubMed ID: 2168678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
